Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

CYPHCYPH
Showing 4 of 9 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in LEAP THERAPEUTICS INC

No. Baker Bros. Advisors exited its CYPH (Leap Therapeutics) position in Q2 2025. Its Q1 2025 13F listed 404,744 shares worth $123,487. Baker Bros. Advisors first reported CYPH in Q2 2023 and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$3M

Total Shares Change

-1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$0.30
0
2025-Q1
Decreased
404,744
-65.5%
$123,4870.0%$0.31
0
2024-Q4
Unchanged
1.2M
0.0%
$3.4M0.0%$2.88
0
2024-Q3
Unchanged
1.2M
0.0%
$3M0.0%$2.57
0

Other major holders of CYPH: BALYASNY ASSET MANAGEMENT L.P., Point72 Asset Management, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used